The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of Tyrosine Kinase Inhibitors.

Xiu, Fangrui; Rausch, Magdalena; Gai, Zhibo; Su, Shanshan; Wang, Shijun; Visentin, Michele

Xiu, Fangrui; Rausch, Magdalena; Gai, Zhibo; Su, Shanshan; Wang, Shijun; Visentin, Michele.

Afiliación

Xiu F; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Rausch M; Department of Nephrology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China.
Gai Z; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland.
Su S; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland.
Wang S; Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Visentin M; Department of Nephrology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China.

Int J Mol Sci ; 24(3)2023 Jan 20.

Article en En | MEDLINE | ID: mdl-36768423

Asunto(s)

Neoplasias; Humanos; Calidad de Vida; Interacciones Farmacológicas; Proteínas de Transporte de Membrana; Neoplasias/tratamiento farmacológico; Cationes; Proteínas de Transporte de Catión Orgánico/genética

Palabras clave

SLC; TKI; drugdrug interaction; organic cation transporter; pharmacokinetics; tyrosine kinase

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google